Pharmacological intervention with beta-blockers is indicated for patients with hypertension refractory to lifestyle modifications. Dosage titration should be performed gradually to minimize adverse hemodynamic effects. Concurrent administration with calcium channel blockers necessitates careful monitoring for potential bradycardia and atrioventricular conduction abnormalities.
